Z-WEHD-FMK: Irreversible Caspase-5 Inhibitor for Inflammation and Pathogenesis Research

Executive Summary: Z-WEHD-FMK (CAS 210345-00-9) is a potent, cell-permeable, and irreversible inhibitor of inflammatory caspases, notably caspase-1, caspase-4, and caspase-5, as demonstrated in cellular and infectious disease models (APExBIO). It blocks proteolytic cleavage events essential for pyroptosis and inflammation, such as golgin-84 processing in host-pathogen interactions (Padia et al., 2025). Quantitative benchmarks show that 80 μM Z-WEHD-FMK inhibits Chlamydia-induced Golgi fragmentation and reduces bacterial load by 100-fold in HeLa cells. The compound is insoluble in water but dissolves efficiently in ethanol and DMSO, and must be stored at -20°C. Z-WEHD-FMK is a validated molecular tool for dissecting caspase signaling in inflammation, apoptosis, and microbial pathogenesis (see detailed review).

Biological Rationale

Caspases are cysteine proteases that play central roles in inflammation and apoptosis. Inflammatory caspases, including caspase-1, -4, and -5, mediate cytokine processing and pyroptotic cell death (Padia et al., 2025). Pyroptosis is a pro-inflammatory form of programmed cell death, characterized by gasdermin D cleavage and plasma membrane pore formation. Canonical pyroptosis is triggered by inflammasome assembly and caspase-1 activation, while non-canonical pathways involve direct activation of caspase-4/5 by intracellular LPS (Surface Antigen, 2023). Blocking these caspases with specific inhibitors like Z-WEHD-FMK enables precise dissection of cell death, cytokine release, and host defense mechanisms. This inhibitor is widely used to distinguish caspase-dependent events from other forms of cell death.

Mechanism of Action of Z-WEHD-FMK

Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) is a peptide-based, cell-permeable, and irreversible caspase inhibitor. It covalently binds to the catalytic cysteine of caspase-1, -4, and -5, preventing substrate cleavage (Z-WEHD-FMK.com). The FMK (fluoromethyl ketone) group forms an irreversible thioether adduct with the enzyme active site. Its specificity is defined by the WEHD tetrapeptide motif, mimicking natural caspase substrates. Z-WEHD-FMK blocks key proteolytic events in both canonical (inflammasome-driven) and non-canonical (LPS-driven) pyroptosis. Notably, it inhibits cleavage of golgin-84, a process required for Chlamydia trachomatis-induced Golgi fragmentation and bacterial replication (Golgi-mTurquoise2, 2023). By preventing these cleavage events, Z-WEHD-FMK suppresses downstream inflammatory and apoptotic signaling.

Evidence & Benchmarks

• In HeLa cells infected with Chlamydia trachomatis, treatment with 80 μM Z-WEHD-FMK for 9 hours blocks golgin-84 cleavage and reduces infectious bacterial progeny by ~2 logs (APExBIO).
• Z-WEHD-FMK irreversibly inhibits caspase-1, -4, and -5 in cell-based and biochemical assays (Padia et al., 2025).
• In cell death studies, Z-WEHD-FMK prevents pyroptosis initiated by both canonical (ASC/NLRP3-dependent) and non-canonical (LPS-induced) pathways (Padia et al., 2025).
• Solubility: Insoluble in water; soluble in ethanol (≥26.32 mg/mL, ultrasonic assistance) and DMSO (≥46.33 mg/mL) (APExBIO).
• Storage: -20°C, avoid long-term solution storage; instability reported above -20°C or in aqueous buffers (APExBIO).
• Does not inhibit non-caspase cysteine proteases at the tested concentrations (Z-WEHD-FMK.com).

For an expanded discussion and application context, see Decoding Caspase Signaling; this article provides updated experimental benchmarks and clarifies mechanistic distinctions in non-canonical pyroptosis beyond previous reviews.

Applications, Limits & Misconceptions

Primary Applications:

• Dissecting inflammatory caspase function in cell models of infection, inflammation, and apoptosis (detailed review).
• Blocking golgin-84 cleavage to study Chlamydia pathogenesis and lipid trafficking (APExBIO).
• Preventing pyroptotic cell death in models where caspase-1/4/5 are activated (Padia et al., 2025).
• Apoptosis and inflammation signaling assays requiring irreversible caspase inhibition (Z-WEHD-FMK.com).

Common Pitfalls or Misconceptions

• Z-WEHD-FMK is not effective against initiator caspases (e.g., caspase-8, -9) due to substrate specificity.
• It does not inhibit proteases outside the caspase family at standard concentrations.
• Irreversibility means that off-target effects persist; washout will not restore enzyme activity.
• Solubility limitations preclude use in aqueous buffers; must use DMSO or ethanol-based stocks.
• Long-term storage of diluted solutions leads to degradation and loss of potency.

See Unveiling Novel Mechanisms for a detailed mechanistic exploration of caspase-5 selectivity; this article updates those findings with expanded benchmarks in Chlamydia-infected models.

Workflow Integration & Parameters

Experimental Conditions:

• Typical use: 80 μM Z-WEHD-FMK, 9h incubation in Chlamydia-infected HeLa cells (APExBIO).
• Solubilize using DMSO (≥46.33 mg/mL) or ethanol (≥26.32 mg/mL, ultrasonic assistance).
• Prepare fresh solutions prior to use; avoid freeze-thaw cycles and long-term storage in solution.
• Store lyophilized product at -20°C, protected from light and moisture.
• For apoptosis or inflammation assays, pre-incubate cells with Z-WEHD-FMK for 1–2 h before stimulant challenge.

For advanced workflows and troubleshooting, consult Advanced Strategies for Targeting Inflammatory Caspases; this resource complements our protocol with practical tips for non-canonical pathway dissection.

Conclusion & Outlook

Z-WEHD-FMK, available from APExBIO, is a gold-standard tool for irreversible inhibition of inflammatory caspases in cellular and infectious disease models. Its validated application in blocking pyroptosis, Golgi fragmentation, and bacterial pathogenesis underscores its utility in mechanistic research. Ongoing studies continue to clarify the nuanced roles of caspase-5 and non-canonical pyroptosis in inflammation and infection. Proper handling, solubility management, and experimental design are critical for reliable results. Z-WEHD-FMK will remain central to next-generation investigations of caspase signaling and host-pathogen interactions.